Pfizer charged the NHS prices between 780% and 1,600% higher than itpreviously did according to the CMA.
(Dan Kitwood/PA)
(Picture: PA Archive)The Competition and Markets Authority has slapped US pharma giant Pfizer with a £63 million fine after it was accused of overcharging the NHS.
The CMA said the company had charged unfairly high prices for phenytoin sodium, an epilepsy drug, for over 4 years.
